Literature DB >> 28456687

Oxytocin receptor neurotransmission in the dorsolateral bed nucleus of the stria terminalis facilitates the acquisition of cued fear in the fear-potentiated startle paradigm in rats.

Mahsa Moaddab1, Joanna Dabrowska2.   

Abstract

Oxytocin (OT) is a hypothalamic neuropeptide that modulates fear and anxiety-like behaviors. Dorsolateral bed nucleus of the stria terminalis (BNSTdl) plays a critical role in the regulation of fear and anxiety, and expresses high levels of OT receptor (OTR). However, the role of OTR neurotransmission within the BNSTdl in mediating these behaviors is unknown. Here, we used adult male Sprague-Dawley rats to investigate the role of OTR neurotransmission in the BNSTdl in the modulation of the acoustic startle response, as well as in the acquisition and consolidation of conditioned fear using fear potentiated startle (FPS) paradigm. Bilateral intra-BNSTdl administration of OT (100 ng) did not affect the acquisition of conditioned fear response. However, intra-BNSTdl administration of specific OTR antagonist (OTA), (d(CH2)51, Tyr(Me)2, Thr4, Orn8, des-Gly-NH29)-vasotocin, (200 ng), prior to the fear conditioning session, impaired the acquisition of cued fear, without affecting a non-cued fear component of FPS. Neither OTA, nor OT affected baseline startle or shock reactivity during fear conditioning. Therefore, the observed impairment of cued fear after OTA infusion resulted from the specific effect on the formation of cued fear. In contrast to the acquisition, neither OTA nor OT affected the consolidation of FPS, when administered after the completion of fear conditioning session. Taken together, these results reveal the important role of OTR neurotransmission in the BNSTdl in the formation of conditioned fear to a discrete cue. This study also highlights the role of the BNSTdl in learning to discriminate between threatening and safe stimuli.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; BNST; Fear; Learning; Oxytocin; Startle

Mesh:

Substances:

Year:  2017        PMID: 28456687      PMCID: PMC5553312          DOI: 10.1016/j.neuropharm.2017.04.039

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  60 in total

1.  Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder.

Authors:  C Grillon; C A Morgan
Journal:  J Abnorm Psychol       Date:  1999-02

2.  Evoked axonal oxytocin release in the central amygdala attenuates fear response.

Authors:  H Sophie Knobloch; Alexandre Charlet; Lena C Hoffmann; Marina Eliava; Sergey Khrulev; Ali H Cetin; Pavel Osten; Martin K Schwarz; Peter H Seeburg; Ron Stoop; Valery Grinevich
Journal:  Neuron       Date:  2012-02-09       Impact factor: 17.173

3.  Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquisition and extinction.

Authors:  Nisrine Lahoud; Mouna Maroun
Journal:  Psychoneuroendocrinology       Date:  2013-10       Impact factor: 4.905

Review 4.  Functional Heterogeneity in the Bed Nucleus of the Stria Terminalis.

Authors:  Nur Zeynep Gungor; Denis Paré
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

5.  5-HT2C receptors in the BNST are necessary for the enhancement of fear learning by selective serotonin reuptake inhibitors.

Authors:  Eliza Pelrine; Sara Diana Pasik; Leyla Bayat; Debora Goldschmiedt; Elizabeth P Bauer
Journal:  Neurobiol Learn Mem       Date:  2016-10-20       Impact factor: 2.877

6.  Oxytocin enhances the expression of morphine-induced conditioned place preference in rats.

Authors:  Mahsa Moaddab; Brian I Hyland; Colin H Brown
Journal:  Psychoneuroendocrinology       Date:  2015-01-14       Impact factor: 4.905

7.  Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.

Authors:  D L Walker; M Davis
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

8.  Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography.

Authors:  E Tribollet; C Barberis; S Jard; M Dubois-Dauphin; J J Dreifuss
Journal:  Brain Res       Date:  1988-02-23       Impact factor: 3.252

9.  Neuronal correlates of fear conditioning in the bed nucleus of the stria terminalis.

Authors:  Darrell Haufler; Frank Z Nagy; Denis Pare
Journal:  Learn Mem       Date:  2013-10-16       Impact factor: 2.460

10.  Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala.

Authors:  Catherine A Marcinkiewcz; Christopher M Mazzone; Giuseppe D'Agostino; Lindsay R Halladay; J Andrew Hardaway; Jeffrey F DiBerto; Montserrat Navarro; Nathan Burnham; Claudia Cristiano; Cayce E Dorrier; Gregory J Tipton; Charu Ramakrishnan; Tamas Kozicz; Karl Deisseroth; Todd E Thiele; Zoe A McElligott; Andrew Holmes; Lora K Heisler; Thomas L Kash
Journal:  Nature       Date:  2016-08-24       Impact factor: 49.962

View more
  13 in total

1.  Mechanistic substrates of a life history transition in male prairie voles: Developmental plasticity in affiliation and aggression corresponds to nonapeptide neuronal function.

Authors:  Aubrey M Kelly; Alexander G Saunders; Alexander G Ophir
Journal:  Horm Behav       Date:  2018-02-03       Impact factor: 3.587

2.  Threat imminence dictates the role of the bed nucleus of the stria terminalis in contextual fear.

Authors:  Travis D Goode; Gillian M Acca; Stephen Maren
Journal:  Neurobiol Learn Mem       Date:  2019-11-15       Impact factor: 2.877

3.  Limbic Neuropeptidergic Modulators of Emotion and Their Therapeutic Potential for Anxiety and Post-Traumatic Stress Disorder.

Authors:  Paul J Marvar; Raül Andero; Rene Hurlemann; Tiffany R Lago; Moriel Zelikowsky; Joanna Dabrowska
Journal:  J Neurosci       Date:  2021-01-20       Impact factor: 6.167

4.  Ionic signalling mechanisms involved in neurokinin-3 receptor-mediated augmentation of fear-potentiated startle response in the basolateral amygdala.

Authors:  Cody A Boyle; Binqi Hu; Kati L Quaintance; Morgan R Mastrud; Saobo Lei
Journal:  J Physiol       Date:  2022-09-13       Impact factor: 6.228

5.  Extrahypothalamic oxytocin neurons drive stress-induced social vigilance and avoidance.

Authors:  Natalia Duque-Wilckens; Lisette Y Torres; Sae Yokoyama; Vanessa A Minie; Amy M Tran; Stela P Petkova; Rebecca Hao; Stephanie Ramos-Maciel; Roberto A Rios; Kenneth Jackson; Francisco J Flores-Ramirez; Israel Garcia-Carachure; Patricia A Pesavento; Sergio D Iñiguez; Valery Grinevich; Brian C Trainor
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

6.  Oxytocin excites BNST interneurons and inhibits BNST output neurons to the central amygdala.

Authors:  Walter Francesconi; Fulvia Berton; Valentina Olivera-Pasilio; Joanna Dabrowska
Journal:  Neuropharmacology       Date:  2021-05-07       Impact factor: 5.273

Review 7.  The Oxytocin-Vasopressin Pathway in the Context of Love and Fear.

Authors:  C Sue Carter
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-22       Impact factor: 5.555

8.  Oxytocin receptors in the dorsolateral bed nucleus of the stria terminalis (BNST) bias fear learning toward temporally predictable cued fear.

Authors:  Daisy Martinon; Paulina Lis; Alexandra N Roman; Patricio Tornesi; Sarah V Applebey; Garrett Buechner; Valentina Olivera; Joanna Dabrowska
Journal:  Transl Psychiatry       Date:  2019-04-18       Impact factor: 6.222

9.  Corticotropin-Releasing Factor Receptors Modulate Oxytocin Release in the Dorsolateral Bed Nucleus of the Stria Terminalis (BNST) in Male Rats.

Authors:  Daisy Martinon; Joanna Dabrowska
Journal:  Front Neurosci       Date:  2018-03-21       Impact factor: 4.677

10.  Suppressed acoustic startle response in traumatic brain injury masks post-traumatic stress disorder hyper-responsivity.

Authors:  Grant M Liska; Jea-Young Lee; Kaya Xu; Paul R Sanberg; Cesario V Borlongan
Journal:  Neuroreport       Date:  2018-08-01       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.